Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship

Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship (c) ECHA
Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship (c) ECHA

The European Chemical Industry Council (CEFIC) has appointed Sylvie Lemoine, senior manager Government Affairs at Dow, as its executive director Product Stewardship effective immediately. She succeeds Peter Smith, who has retired from the organization.

In her new role, Lemoine will be responsible for the key chemical legislation topics, including the implementation of REACh, an EU framework for endocrine disruptors, and the interface between chemicals, products and waste.

Marco Mensink, CEFIC’s director general, said: “Sylvie brings a unique skill set to the Product Stewardship team. The combination of her advocacy experience in Brussels with an in-depth technical knowledge of the EU chemicals legislation makes her a perfect fit for this role. I would like to thank outgoing executive director Peter Smith for his contribution to the Product Stewardship team over the past seven years.”

Lemoine has more than 10 years of experience in EU government affairs. Prior to joining Dow Corning in 2016, she was director for Technical and Regulatory Affairs at the International Association for Soaps, Detergents and Maintenance Products (AISE). She holds a PhD in organic chemistry from the Louis Pasteur University in Strasbourg, France and started her career at ExxonMobil Chemical.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.